4//SEC Filing
Parschauer Karah Herdman 4
Accession 0000950170-24-072621
CIK 0001515673other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 7:47 PM ET
Size
4.8 KB
Accession
0000950170-24-072621
Insider Transaction Report
Form 4
Parschauer Karah Herdman
EVP and Chief Legal Officer
Transactions
- Sale
Common Stock
2024-06-12$45.00/sh−9,806$441,270→ 57,981 total
Footnotes (2)
- [F1]Includes 447 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on April 30, 2024.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001677455
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 7:47 PM ET
- Size
- 4.8 KB